Holen Sie sich die Stockscreener-App
0.5906
4.36%
-0.0269
China Pharma Holdings Inc. Aktie (CPHI) Neueste Nachrichten
Trading Recap: Does ALLT have strong EBITDA margins2026 Growth vs Value & AI Driven Stock Reports - baoquankhu1.vn
Aug Sentiment: Why is Alexanders Inc stock going downProduct Launch & Weekly High Momentum Picks - baoquankhu1.vn
symbol__ Stock Quote Price and Forecast - CNN
US Market Recap: Can PBHC generate free cash flowLayoff News & Smart Money Movement Alerts - baoquankhu1.vn
Ascentage Pharma Group International (NASDAQ:AAPG) Raised to "Strong-Buy" at China Intl Cap - MarketBeat
Market Catalysts: Is China Pharma Holdings Incs ROE strong enough2026 Volume Leaders & High Conviction Trade Alerts - baoquankhu1.vn
Earnings Risk: Can China Pharma Holdings Inc expand its profit marginsVolume Spike & Low Drawdown Trading Strategies - baoquankhu1.vn
China Pharma (NYSE:CPHI) & Acerus Pharmaceuticals (OTCMKTS:ASPCF) Financial Comparison - Defense World
CUPR PE Ratio & Valuation, Is CUPR Overvalued - Intellectia AI
DRMA Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Stock List: Research Stocks from Around the World - GuruFocus
China Pharma Holdings, Inc. (XQJ.DE) Analyst insights, Price targets and Recommendations - Yahoo Finance Singapore
China Pharma Holdings, Inc. (XQJ.DE) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
China Pharma Delays 10-K but Shows Narrowing Losses - The Globe and Mail
China Pharma Holdings 2026 Annual Report: Strategic Focus on Generic Drugs, Market Expansion, and Innovation in China’s Pharmaceutical Industry - Minichart
China Pharma Holdings Files For Non-Timely 10-K With US SEC - TradingView
China Pharma Holdings 10-K: Revenue $4.14M, Loss per Share $(0.74) - TradingView — Track All Markets
China Pharma (NYSE American: CPHI) details 2025 losses and China policy risks - Stock Titan
China Pharma Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Buy Signal: Can China Pharma Holdings Inc keep up with sector leadersBull Run & Trade Opportunity Analysis - baoquankhu1.vn
USA Stocks: Research Stocks from USA Stock Market - GuruFocus
US pharma giant reaches $2.75 billion deal with China-based biotech company for AI-developed drugs - Yahoo Finance
Risk Report: How does China Pharma Holdings Inc perform in inflationary periods2026 Growth vs Value & Capital Protection Trade Alerts - baoquankhu1.vn
China NT Pharma Group Announces Reduced Net Loss for 2025 After One-Off Non-Cash Gain – Profit Warning Update - Minichart
Market Outlook: How does China Pharma Holdings Inc perform in inflationary periodsForecast Cut & AI Forecasted Entry/Exit Points - baoquankhu1.vn
Aug Technicals: Can China Pharma Holdings Inc expand into new marketsQuarterly Investment Review & Stepwise Trade Signal Implementation - baoquankhu1.vn
Jobs Data: Is China Pharma Holdings Incs ROE strong enough2026 Year in Review & Free Weekly Watchlist of Top Performers - baoquankhu1.vn
Aug Drivers: Can China Pharma Holdings Inc keep up with sector leadersTrade Analysis Report & Low Volatility Stock Recommendations - baoquankhu1.vn
If You Invested $1,000 in China Pharma (CPHI) - Stock Titan
Quarterly Trades: How does China Pharma Holdings Inc perform in inflationary periodsMarket Sentiment Report & AI Enhanced Execution Alerts - baoquankhu1.vn
MGRX Financials: Revenue Breakdown, Margins & Competitor Comparison - intellectia.ai
China Medical System Holdings SEHK 867 Margin Decline Tests Bullish Growth Narrative - simplywall.st
Market Outlook: Will China Pharma Holdings Inc be affected by tariffs2026 Key Lessons & Safe Swing Trade Setups - baoquankhu1.vn
Assessing China Medical System (SEHK:867) Valuation After A Recent Share Price Pullback - simplywall.st
Investment Recap: How correlated is NCDL to the S P500Long Setup & Weekly Momentum Stock Picks - baoquankhu1.vn
Bearish Setup: How does China Pharma Holdings Inc perform in inflationary periods2026 Winners & Losers & Low Drawdown Investment Strategies - baoquankhu1.vn
Volume Recap: What are the analyst revisions for Amdocs LimitedIs CTEV stock a good investment in YEARProduct Launch & AI Based Buy and Sell Signals - baoquankhu1.vn
Can China Pharma Holdings Inc lead its sector in growth2026 Momentum Check & Target Return Focused Picks - baoquankhu1.vn
Q4 and annual financial update released, Corbus Pharmaceuticals Holdings, Inc. outlines - Traders Union
Will Pony AI Inc. Depositary Receipt stock continue dividend increases2026 Support & Resistance & Reliable Intraday Trade Plans - Naître et grandir
How GreenTree Hospitality Group Ltd. American stock performs during market turbulencePortfolio Risk Report & Weekly Return Optimization Plans - Naître et grandir
Volume Report: Is Central Plains Bancshares Inc backed by strong institutional buyingRisk Management & Community Consensus Trade Alerts - baoquankhu1.vn
Is Southland Holdings Inc. Equity Warrant stock a dividend growth opportunityIPO Watch & Risk Controlled Daily Trade Plans - Naître et grandir
Fed Watch: Is China Pharma Holdings Incs ROE strong enoughJuly 2025 Trade Ideas & Stepwise Trade Execution Plans - baoquankhu1.vn
Trade Recap: Can China Pharma Holdings Inc expand into new marketsJuly 2025 Intraday Action & Community Consensus Trade Signals - baoquankhu1.vn
Form 10-KAnnual Reports - Stock Titan
China Pharma Expands R&D Portfolio With Patent Acquisition - TipRanks
Quarterly Risk: Can China Pharma Holdings Inc keep up with sector leadersJuly 2025 WrapUp & Fast Gain Stock Trading Tips - baoquankhu1.vn
getLinesFromResByArray error: size == 0 - mfd.ru
Naproxen Patches Market Growth Fueled by Shift from Oral Nsaids, Forecast to 2035News and Statistics - IndexBox
CPHI Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
GLMD PE Ratio & Valuation, Is GLMD Overvalued - Intellectia AI
Inflation Data: Is Blackstone Inc affected by consumer sentimentQuarterly Earnings Summary & Safe Investment Capital Preservation Plans - baoquankhu1.vn
Risk Check: Is China Pharma Holdings Inc part of any ETFQuarterly Growth Report & Smart Investment Allocation Insights - baoquankhu1.vn
Risk Analysis: Can NESRW lead its sector in growthShare Buyback & Trade Opportunity Analysis - baoquankhu1.vn
BIT Capital GmbH Reduces Holdings in BridgeBio Pharma, Inc. $BBIO - Defense World
CPHI Should I Buy - Intellectia AI
Winners Losers: Is GoldMining Inc part of any ETFMarket Sentiment Summary & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
The China factor: US pharma group campaigns for increased competitiveness - Yahoo Finance
PAPLD Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
AI Drug Discovery Push And New Kidney Drug Trial Could Be A Game Changer For China Medical System Holdings (SEHK:867) - simplywall.st
Profit Review: Should I set a stop loss on SGRPLayoff News & Technical Buy Zone Confirmation - baoquankhu1.vn
00863 Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Most and least shorted healthcare stocks with up to $2B market cap - Seeking Alpha
Plasma Fractionation Market Size, Share, Trend, Scope Report 2026 to 2035 - Insightace Analytic
Can China Pharma Holdings Inc. stock maintain growth trajectory2025 Investor Takeaways & Long-Term Safe Return Strategies - mfd.ru
Will China Pharma Holdings Inc. stock maintain momentum in 2025Gap Up & Verified Entry Point Detection - mfd.ru
What margin trends mean for China Pharma Holdings Inc. stockJuly 2025 Trends & Technical Pattern Based Signals - mfd.ru
1.68%
0.58%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):